Correlation of endothelin A receptor expression to prognosis of nasopharyngeal carcinoma

BACKGROUND & OBJECTIVE: Endothelin A receptor (ET(A)R) activation contributes to tumor growth and metastasis, including cell proliferation, cell death, angiogenesis, and metastatic spread. In this study, we evaluated correlation of ET(A)R expression to clinical features of nasopharyngeal carcinoma (NPC), and explored its correlation to prognosis.

METHODS: Expression of ET(A)R in 153 specimens of NPC was detected by SABC immunohistochemistry.

RESULTS: Positive rate of ET(A)R was 73.9% in the 153 NPC specimens. No correlation was found between ET(A)R expression and gender, age, T stage, N stage, and TNM stage of the patients. The 3-year overall survival rate, relapse-free survival rate, and distant metastasis-free survival rate were significantly higher in ET(A)R-negative patients than in ET(AR-positive patients (87.5% vs. 73.2%, P = 0.029; 80.0% vs. 57.3%, P = 0.009; and 89.9% vs. 70.4%, P = 0.012), except for local relapse-free survival rate (86.9% vs. 80.2%, P = 0.228). Cox multivariate analysis showed that ET(A)R expression, gender, age, T stage, and N stage were independent prognostic factors, which affected overall survival, relapse-free survival, and distant metastasis.

CONCLUSION: ET(A)R expression is an important distant metastasis-related risk factor for patients with NPC; its overexpression indicates poor prognosis.

Medienart:

Artikel

Erscheinungsjahr:

2005

Erschienen:

2005

Enthalten in:

Zur Gesamtaufnahme - volume:24

Enthalten in:

Ai zheng = Aizheng = Chinese journal of cancer - 24(2005), 5 vom: 12. Mai, Seite 611-5

Sprache:

Chinesisch

Beteiligte Personen:

Mai, Hai-Qiang [VerfasserIn]
Zeng, Zong-Yuan [VerfasserIn]
Zhang, Hui-Zhong [VerfasserIn]
Hou, Jing-Hui [VerfasserIn]
Mo, Hao-Yuan [VerfasserIn]
Guo, Xiang [VerfasserIn]
Min, Hua-Qing [VerfasserIn]
Hong, Ming-Huang [VerfasserIn]

Themen:

English Abstract
Journal Article
Receptor, Endothelin A
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 07.11.2006

Date Revised 13.03.2015

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM155340662